Lino Cardenas Christian L, Kaminski Naftali, Kass Daniel J
Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Drug Discov Today Dis Models. 2013 Fall;10(3):e145-e151. doi: 10.1016/j.ddmod.2012.11.003.
MicroRNAs are implicated in many biological and pathological processes and are emerging as key actors in lung health and disease. Specific patterns of dysregulated microRNAs have been found in idiopathic pulmonary fibrosis (IPF), an untreatable interstitial lung disease of unknown etiology. IPF is characterized by dramatic and extensive phenotypic changes in the lung that include alveolar cell hyperplasia, fibroblast proliferation and formation of myofibroblast foci, deposition of extracellular matrix, and changes in lung transcriptional programming. Here, we discuss the latest insights about the role of microRNAs in lung fibrosis with a focus on the contribution of animal models of disease to the derivation of these insights.
微小RNA参与许多生物学和病理过程,正成为肺部健康与疾病的关键因素。在特发性肺纤维化(IPF)中发现了特定的微小RNA失调模式,IPF是一种病因不明的不可治愈的间质性肺病。IPF的特征是肺部出现显著且广泛的表型变化,包括肺泡细胞增生、成纤维细胞增殖和肌成纤维细胞灶形成、细胞外基质沉积以及肺转录程序的改变。在此,我们讨论关于微小RNA在肺纤维化中作用的最新见解,重点关注疾病动物模型对这些见解推导的贡献。